0
No hay productos en el carro de la compra
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Casa > CXCL9

CXCL9

Brief Information

Name:C-X-C motif chemokine 9
Target Synonym:C-X-C motif chemokine 9,Gamma-interferon-induced monokine,Monokine induced by interferon-gamma (HuMIG; MIG),Small-inducible cytokine B9,SCYB9,Crg-10,Humig,CMK,MIG,Monokine Induced By Gamma Interferon,Monokine Induced By Interferon-Gamma,Gamma-Interferon-Induced Monokine,Chemokine (C-X-C Motif) Ligand 9,Small-Inducible Cytokine B9,C-X-C Motif Chemokine 9,HuMIG
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

Por estado del producto :
Por categoría de producto :
Por especies :
Por etiqueta :
Por Conjugado::
Cat. No. Especies Descripción del producto Estructura Pureza Característica
CX9-H51H3 Human Human CXCL9 Protein, His Tag
CX9-H51H3-structure
CX9-H51H3-sds
ACRO Quality

Part of Bioactivity data

CX9-H51H3-ELISA
 CXCL9 ELISA

Immobilized Human CXCL9 Protein, His Tag (Cat. No. CX9-H51H3) at 5 μg/mL (100 μL/well) can bind Human CXCR3 Protein, Flag,His Tag (Cat. No. CX3-H52D5) with a linear range of 0.019-0.313 μg/mL (QC tested).

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
NG-641 EnAd-FAP-BiTE; EnAd-FAP-Tac; NG-641; NG-aFAP Phase 1 Clinical Akamis Bio Ltd, University Of Oxford Squamous Cell Carcinoma of Head and Neck; Neoplasms, Glandular and Epithelial; Neoplasm Metastasis Details
NG-641 EnAd-FAP-BiTE; EnAd-FAP-Tac; NG-641; NG-aFAP Phase 1 Clinical Akamis Bio Ltd, University Of Oxford Squamous Cell Carcinoma of Head and Neck; Neoplasms, Glandular and Epithelial; Neoplasm Metastasis Details

This web search service is supported by Google Inc.

totop
Email
Correo electrónico
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland

Dejar un mensaje